Stories about Similac

Subscribe to Similac

29.07.2020 – 15:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH announces the foundation of Jennewein Biotech Corp. USA

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, a market leading and science-based company for developing and producing human milk oligosaccharides (HMOs) and rare monosaccharides, announced today that it has established its subsidiary in the USA. Jennewein Biotech USA Corporation, a Delaware Corporation, utilizing warehouses in Chicago, IL and Columbus, OH, will ...

more
10.01.2020 – 12:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG. Nestlé offers its infant formula Beba Supreme which contains two human milk oligosaccharides - ...

more
08.01.2020 – 17:00

Jennewein Biotechnologie GmbH
Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

Rheinbreitbach (ots) - Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the ...

more
11.09.2019 – 17:00

Jennewein Biotechnologie GmbH
Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

more
05.02.2019 – 10:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market

Hohhot, China & Rheinbreitbach, Germany (ots) - - China represents the largest market for baby food globally - Human milk oligosaccharides are key for the development of a healthy infant microbiome Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), ...

more
05.07.2018 – 12:00

Jennewein Biotechnologie GmbH
Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany

Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...

more

1